Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma The European Organisation for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study

Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma The European Organisation for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study

Bibliographic Details
Main Authors: Penel, N, Glabbeke, M V, Mathoulin-Pelissier, S, Judson, I, Sleijfer, S, Bui, B, Schoffski, P, Ouali, M, Marreaud, S, Brouste, V, Duhamel, A, Hohenberger, P, Blay, J-Y
Format: Online
Language:English
Published: Nature Publishing Group 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101912/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101912/

Similar Items